Abstract Achievement Award

Spring Conference March 24, 2023: Call for Abstracts

Submission Opens: 1/09/2023 | Submission Closes: 02/02/2023

The West Virginia Oncology Society (WVOS) invites you to participate in the WVOS Outstanding Hematology-Oncology Trainee Recognition Competition by submitting an abstract for our Spring Conference held on Friday, March 24, 2023.

All submitted abstracts will be reviewed by the WVOS review committee. The committee will select up to 10 of the best abstracts for awards up to $1,000 to be presented at the WVOS Spring Conference. The first authors of the winning abstracts will be invited to attend the WVOS conference and display a research poster. The author of the highest rated abstract will also be requested to present 10 minutes of their research within 5 power point slides to conference attendees in addition to displaying a poster of research. First authors of each winning abstract will receive a participation award and one night hotel accommodations during the spring conference.

Abstract categories may address the myriad of issues facing oncology and can be previously evaluated. Suggested topics are, but not limited to:

Medical Oncology
Surgical Oncology
Cardio-Oncology
Survivorship
Developmental Therapeutics
Hematology
Radiation Oncology

Palliative Care
Clinical Trials/Interventions
Pediatric Oncology or hematology or bone marrow transplantation as a modality
Neuro-Oncology
Case Series
Pilot Studies
Retrospective Chart Review

Submission Instructions

There is a 300-word limit, excluding spaces, authors, and institutions.
The title of your abstract should include significant words that reflect the content of the abstract but not refer to the study results or conclusions.
Do not use proprietary names alone in the title or body of the abstract. If necessary, you may include a proprietary name in parentheses directly after the generic name on first use in the body of the abstract.
Abstracts will be judged solely based on the data in the submitted abstract. Statements such as “further data will be available” are discouraged.
Place abbreviations in parentheses immediately after the first mention of a term or phrase; the abbreviation can then be used throughout the abstract. Take particular care to identify complex chemotherapy regimens accurately.
With your abstract include a brief biography and/or CV, disclosure(s), your name, institution (affiliation), address, telephone number, fax number, and email address. As the First Author (presenter), you will receive all future correspondence from WVOS.
Verify that all co-authors are aware of the contents of the abstract and support its data.
Abstracts and CV’s must be submitted electronically via email as a WORD or PDF document to Amanda Impellizzeri by the deadline of February 2, 2023. Each first author will receive an email verifying that WVOS has received the abstract.
Include the name and institution for each Co-Author associated with the abstract.

Submissions and questions should be submitted to Amanda Impellizzeri aimpellizzeri@accc-cancer.org